Childhood T Acute Lymphoblastic Leukemia: Clinical Trials

2 trials for Childhood T Acute Lymphoblastic Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Active not recruiting 1, Completed 1

Follow Childhood T Acute Lymphoblastic Leukemia: new trials by email Literature Review of Childhood T Acute Lymphoblastic Leukemia trials Research Report on Childhood T Acute Lymphoblastic Leukemia

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma
Bortezomib, Cyclophosphamide, Cytarabine - Adult T Acute Lymphoblastic Leukemia, Ann Arbor Stage II Adult Lymphoblastic Lymphoma
Phase 3Active not recruitingNational Cancer Institute (NCI)8472014-10-042026-10-21
Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Asparaginase, Biospecimen Collection, Bone Marrow Biopsy - Acute Lymphoblastic Leukemia, Acute Undifferentiated Leukemia
Phase 3CompletedChildren's Oncology Group2182008-01-152024-07-15

Narrower conditions

Leukemia, Biphenotypic, Acute (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)  ·  Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1)

Broader conditions

Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Immune System Diseases (2)  ·  Immunoproliferative Disorders (2)  ·  Leukemia (2)  ·  Leukemia, Lymphoid (2)  ·  Lymphatic Diseases (2)  ·  Lymphoproliferative Disorders (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

Interventions

Calcium Dobesilate (2)  ·  Cyclophosphamide (2)  ·  Cytarabine (2)  ·  Daunorubicin (2)  ·  Dexamethasone (2)  ·  Etoposide (2)  ·  Hydrocortisone (2)  ·  Leucovorin (2)  ·  Mercaptopurine (2)  ·  Methotrexate (2)  ·  Vincristine (2)  ·  auricularum (2)  ·  azathiopurine (2)  ·  dexamethasone 21-phosphate (2)  ·  dexamethasone acetate (2)

Sponsors

Children's Oncology Group (1)  ·  National Cancer Institute (NCI) (1)

Countries

Australia (2)  ·  Canada (2)  ·  New Zealand (2)  ·  United States (2)

Top investigators

David T Teachey (1)  ·  Joanne M Hilden (1)

Results publications

PMID 32414848, PMID 35271306, PMID 36603187, PMID 38457359

NIH funding

U10CA098543 (2), U10CA180886 (2)